Follow
Martin K. Bakht
Martin K. Bakht
Dana-Farber Cancer Institute ; Harvard Medical School ; Broad Institute of MIT and Harvard
Verified email at dfci.Harvard.edu - Homepage
Title
Cited by
Cited by
Year
Neuroendocrine differentiation of prostate cancer leads to PSMA suppression
MK Bakht, I Derecichei, Y Li, RM Ferraiuolo, M Dunning, SW Oh, ...
Endocrine-related cancer 26 (2), 131-146, 2019
612019
Influence of androgen deprivation therapy on the uptake of PSMA-targeted agents: emerging opportunities and challenges
MK Bakht, SW Oh, H Youn, GJ Cheon, C Kwak, KW Kang
Nuclear Medicine and Molecular Imaging 51 (3), 202-211, 2017
432017
Scope of nanotechnology-based radiation therapy and thermotherapy methods in cancer treatment
M K Bakht, M Sadeghi, M Pourbaghi-Masouleh, C Tenreiro
Current cancer drug targets 12 (8), 998-1015, 2012
382012
Differential expression of glucose transporters and hexokinases in prostate cancer with a neuroendocrine gene signature: a mechanistic perspective for 18F-FDG imaging of PSMA …
MK Bakht, JM Lovnicki, J Tubman, KF Stringer, J Chiaramonte, ...
Journal of Nuclear Medicine 61 (6), 904-910, 2020
362020
Internal radiotherapy techniques using radiolanthanide praseodymium-142: a review of production routes, brachytherapy, unsealed source therapy
MK Bakht, M Sadeghi
Annals of nuclear medicine 25 (8), 529-535, 2011
332011
A novel technique for simultaneous diagnosis and radioprotection by radioactive cerium oxide nanoparticles: study of cyclotron production of 137mCe
MK Bakht, M Sadeghi, C Tenreiro
Journal of Radioanalytical and Nuclear Chemistry 292 (1), 53-59, 2012
292012
Preparation of radioactive praseodymium oxide as a multifunctional agent in nuclear medicine: expanding the horizons of cancer therapy using nanosized neodymium oxide
MK Bakht, M Sadeghi, SJ Ahmadi, SS Sadjadi, C Tenreiro
Nuclear Medicine Communications 34 (1), 5-12, 2013
272013
Practicality of the cyclotron production of radiolanthanide 142 Pr: a potential for therapeutic applications and biodistribution studies
M Sadeghi, M Bakht, L Mokhtari
Journal of Radioanalytical and Nuclear Chemistry 288 (3), 937-942, 2011
272011
Production of cationic 198 Au 3+ and nonionic 198 Au 0 for radionuclide therapy applications via the nat Au (n, γ) 198 Au reaction
M Sadeghi, H Jabal-Ameli, S Ahmadi, S Sadjadi, M Bakht
Journal of Radioanalytical and Nuclear Chemistry 293 (1), 45-49, 2012
172012
Calcium phosphate nanoparticles cytocompatibility versus cytotoxicity: a serendipitous paradox
MP Masouleh, V Hosseini, M Pourhaghgouy, MK Bakht
Current pharmaceutical design 23 (20), 2930-2951, 2017
142017
Overview of mercury radionuclides and nuclear model calculations of 195 Hg m, g and 197 Hg m, g to evaluate experimental cross section data
M Sadeghi, M Bakhtiari, MK Bakht, M Anjomrouz, L Mokhtari
Physical Review C 85 (3), 034605, 2012
142012
Taxane-induced attenuation of the CXCR2/BCL-2 axis sensitizes prostate cancer to platinum-based treatment
VR de Porras, XC Wang, L Palomero, M Marin-Aguilera, C Solé-Blanch, ...
European urology 79 (6), 722-733, 2021
112021
Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer
NJ Brady, AM Bagadion, R Singh, V Conteduca, L Van Emmenis, E Arceci, ...
Nature communications 12 (1), 1-17, 2021
102021
Radiolabeled nanoceria probes may reduce oxidative damages and risk of cancer: A hypothesis for radioisotope-based imaging procedures
MK Bakht, V Hosseini, H Honarpisheh
Medical Hypotheses 81 (6), 1164-1168, 2013
82013
Nuclear model calculations of charged-particle-induced reaction cross section data for the production of the radiohalogen 34 Cl m
M Bakhtiari, M Sadeghi, MK Bakht, H Ghafoori-Fard
Physical Review C 87 (3), 034621, 2013
82013
Feasibility study of FLUKA Monte Carlo simulation for a beta-emitting brachytherapy source: dosimetric parameters of 142Pr glass seed
M Anjomrouz, MK Bakht, M Sadeghi
Journal of Radioanalytical and Nuclear Chemistry, 1-7, 2016
72016
Bremsstrahlung parameters of praseodymium-142 in different human tissues: a dosimetric perspective for 142Pr radionuclide therapy
MK Bakht, H Jabal-Ameli, SJ Ahmadi, M Sadeghi, S Sadjadi, C Tenreiro
Annals of nuclear medicine 26 (5), 412-418, 2012
72012
The Potential Roles of Radionanomedicine and Radioexosomics in Prostate Cancer Research and Treatment
MK Bakht, SW Oh, DW Hwang, YS Lee, H Youn, LA Porter, GJ Cheon, ...
Current Pharmaceutical Design 23 (20), 2976-2990, 2017
52017
Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells
MK Bakht, JJ Hayward, F Shahbazi-Raz, M Skubal, R Tamura, KF Stringer, ...
Proceedings of the National Academy of Sciences 119 (4), e2025710119, 2022
32022
Cyclin-like proteins tip regenerative balance in the liver to favour cancer formation
BA Fifield, J Talia, C Stoyanovich, MJ Elliott, MK Bakht, A Basilious, ...
Carcinogenesis 41 (6), 850-862, 2020
22020
The system can't perform the operation now. Try again later.
Articles 1–20